CTI BioPharma Soars On FDA's Accelerated Approval Of Vonjo For Myelofibrosis, Thrombocytopenia
1/3 16:15
(RTTNews) - CTI BioPharma Corp. (CTIC) shares are surging more than 51 percent on Tuesday morning after the company announced FDA accelerated approval of Vonjo for the treatment of adult patients with Myelofibrosis and Thrombocytopenia....